Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$41.91 |
52 Week High | US$43.21 |
52 Week Low | US$34.72 |
Beta | 0 |
11 Month Change | -1.17% |
3 Month Change | 1.33% |
1 Year Change | 14.24% |
33 Year Change | 31.49% |
5 Year Change | 81.41% |
Change since IPO | 131.52% |
Recent News & Updates
Recent updates
Shareholder Returns
ZPDH | DE Capital Markets | DE Market | |
---|---|---|---|
7D | -0.5% | 1.4% | 1.5% |
1Y | 14.2% | 28.7% | 12.6% |
Return vs Industry: ZPDH underperformed the German Capital Markets industry which returned 28.7% over the past year.
Return vs Market: ZPDH exceeded the German Market which returned 12.6% over the past year.
Price Volatility
ZPDH volatility | |
---|---|
ZPDH Average Weekly Movement | 1.5% |
Capital Markets Industry Average Movement | 4.9% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 11.7% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ZPDH has not had significant price volatility in the past 3 months.
Volatility Over Time: ZPDH's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | n/a | n/a | ie.spdrs.com/en/professional/etf/spdr-sp-us-health-care-select-sector-ucits-etf-ZPDH-GY |
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. It is co-managed by State Street Global Advisors, Inc. The fund invests in the public equity markets of the United States.
SSgA SPDR ETFs Europe II Public Limited Company - SPDR S&P U.S. Health Care Select Sector UCITS ETF Fundamentals Summary
ZPDH fundamental statistics | |
---|---|
Market cap | €379.41m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs ZPDH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ZPDH income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did ZPDH perform over the long term?
See historical performance and comparison